Rocket Report: Keeping up with Kuiper; New Glenn’s second flight slips

And we don't make you work six and a half days a week, 12 hours a day." Kemp also accused Firefly Aerospace of sending Astra ...

Regeneron Pharmaceuticals, Inc.: Evkeeza (evinacumab-dgnb) ANGPTL3 Antibody Approved in the U.S. for Children as Young as 1 Year Old with Ultra-Rare Form of High Cholesterol

FDA approval extends the indication of Evkeeza to treat younger patients with homozygous hypercholesterolemia (HoFH) HoFH is an inherited condition characterized by extremely high levels of low-densit ...